Search Results - "Chabrol Haas, Laura"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancer

    Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancer by Paladini, Luciano, da Veiga, Cássia Rita Pereira, Cerqueira, Érica, Chabrol Haas, Laura, Datz Abadi, Márcia, Baldotto, Clarissa Seródio

    Published in Journal of medical economics (01-01-2021)
    “…Considering that healthcare systems' financial resources are limited, we aimed to analyze the number needed to treat (NNT) and cost of preventing an event…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  2. 2
    Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective

    Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective by Engel Ayer Botrel, Tobias, Datz Abadi, Márcia, Chabrol Haas, Laura, da Veiga, Cássia Rita Pereira, de Vasconcelos Ferreira, Dominihemberg, Jardim, Denis Leonardo

    Published in Journal of medical economics (01-01-2021)
    “…Considering clinical benefits of new combination therapies for metastatic renal-cell carcinoma (mRCC), this study aims to calculate the number needed to treat…”
    Get more information
    Journal Article
    Save to List
    Saved in:

Search Tools: